This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: John Kenneth Morrow: Innovator in Anti-Cancer Compounds
Introduction
John Kenneth Morrow is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development of anti-cancer compounds. His work focuses on methods and compositions that provide therapeutic utility in treating proliferative diseases such as cancer.
Latest Patents
Morrow holds a patent for anti-cancer compounds, which includes methods and compositions for the treatment of diseases like cancer. His patent specifically discloses chromenone derivatives that can inhibit Skp2, thereby reducing the differentiation of pluripotent, multipotent, or totipotent cells. This innovative approach has the potential to offer new therapeutic options for patients suffering from cancer. He has 1 patent to his name.
Career Highlights
Morrow is affiliated with the University of Texas System, where he continues to advance his research in the field of cancer therapeutics. His work has garnered attention for its potential impact on treatment methodologies and patient outcomes.
Collaborations
Morrow has collaborated with esteemed colleagues such as Chia-Hsin Chan and Shuxing Zhang. Their combined expertise contributes to the ongoing research and development of effective cancer treatments.
Conclusion
John Kenneth Morrow's innovative work in developing anti-cancer compounds highlights his commitment to advancing medical science. His contributions have the potential to significantly impact cancer treatment and improve patient care.